Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo
Xiaomeng Wang(Xi'an Jiaotong University), San‐Qi Zhang(Xi'an Jiaotong University), Yan Li(Xi'an Jiaotong University), Shemin Lu(Second Affiliated Hospital of Xi'an Jiaotong University), Jing Xu(Xi'an Jiaotong University), Minhang Xin(Zhejiang University), Bo-Rui Kang(Xi'an Jiaotong University)
Cited by 36
Related Papers
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
|European Journal of Medicinal Chemistry|2018|168
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
|European Journal of Medicinal Chemistry|2020|120
Strategies to target the Hedgehog signaling pathway for cancer therapy
|Medicinal Research Reviews|2018|108